Body mass index, disease control and airway inflammation in asthmatic patients Source: Annual Congress 2011 - Airways disease comorbidities and general aspects Year: 2011
Inflammatory markers in skeletal muscle of low and normal weight COPD patients Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005
Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006
Current control, airway inflammation, and subsequent exacerbation in patients with asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
The association between obesity and asthma: interactions between systemic and airway inflammation Source: Annual Congress 2008 - Understanding airway inflammation Year: 2008
Association between airway inflammation, disease control and lung function parameters in asthma Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010
Eosinophilic inflammation and muscle mass in chronic airway disease Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021
Are systemic inflammatory markers predictive of loss of lean body mass in COPD patients? Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011
The combination of low fat-free mass and high fat mass is related to functional outcome and systemic inflammation in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014
The impact of obesity on airway and lung parenchyma remodelling in a murine model of chronic allergic asthma Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
The influence of obesity on bronchial hyperresponsiveness, airway and systemic inflammation, lung function and quality of life in patients with asthma Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
Cardiac muscle mass and function are associated with altered body composition in patients with COPD Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007
Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007
Phenotypic markers of asthma and COPD at the tissue level Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005
Airway pathology in asthma Source: Eur Respir J 2001; 18: 18S-23S Year: 2001
The link between upper and lower respiratory disease Source: Annual Congress 2005 - PG18 - Inter-relationships between upper and lower airway diseases Year: 2005
Adiposity, asthma and airway inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 235s Year: 2006
Association between percentage of fat mass and endothelial function in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017
Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective Source: Eur Respir J 2003; 22: 2S-4S Year: 2003
Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003